Bliss GVS Pharma Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma's promoters and promoter group members have submitted their annual declaration under SEBI's Takeover Regulations for the financial year ended March 31, 2025. The promoters collectively hold 3,71,22,024 equity shares, representing 35.23% of the company. All declarants (including individual promoters Narsimha Shibroor Kamath, Shruti Vishal Rao, Vibha Gagan Sharma, Gagan Harsh Sharma, and promoter group members) have confirmed that no new encumbrances have been created on the company's shares during the year. The total number of encumbered (pledged) shares held by promoters stands at Nil as of March 31, 2025.
This is a routine annual compliance filing with no negative implications. The confirmation of zero encumbered shares signals a clean share pledge position, which is a positive indicator for retail investors as it reduces the risk of forced selling or margin call events.